Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Second $20m loan for StemCells Inc alongside Capricor's first under California stem cell programme

This article was originally published in Scrip

Executive Summary

The California Institute of Regenerative Medicine (CIRM) has approved its second round of "disease team" awards, which included two separate $20 million loans to cardiac stem cell specialist Capricor and StemCells Inc, which won a second loan to develop its purified human neural stem cells (HuCNS-SC).

Advertisement

Related Content

StemCells Inc. To Wind Down Operations After Phase II Failure

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC018699

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel